The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies

A high throughput screening system for predicting chemically-induced reproductive organ deformities

Acute effects on brain cholecystokinin-like concentration and anxiety-like behaviour in the female rat upon a single injection of 17β-estradiol

Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk

Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone

Puberty induction in Turner syndrome: Results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels

The evaluation of the immunomodulating properties of ERA-63 a pharmaceutical with estrogenic activity

Xeno-estrogenic compounds in precipitation

Bioavailability and biodegradation of nonylphenol in sediment determined with chemical and bioanalysis

Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: A systematic review

Inhibitors and activation markers of the haemostatic system during hormone therapy: A comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone

The use of metabolising systems for in vitro testing of endocrine disruptors

Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists

Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen

Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables

Alcohol intake and ovarian cancer risk: A pooled analysis of 10 cohort studies

Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis

The effects of 12 weeks of HMR 3339, a novel selective estrogen receptor modulator, on markers of coagulation and fibrinolysis: A randomized, placebo-controlled, double-blind, dose-ranging study in healthy postmenopausal women

Androgenic activity in surface water samples detected using the AR-LUX assay: Indications for mixture effects

What can spores do for us?